143 related articles for article (PubMed ID: 35128470)
21. Do Serum Urate-associated Genetic Variants Influence Gout Risk in People Taking Diuretics? Analysis of the UK Biobank.
Narang RK; Gamble G; Phipps-Green AJ; Topless R; Cadzow M; Stamp LK; Merriman TR; Dalbeth N
J Rheumatol; 2020 Nov; 47(11):1704-1711. PubMed ID: 32007933
[TBL] [Abstract][Full Text] [Related]
22. Association between ethnic background and COVID-19 morbidity, mortality and vaccination in England: a multistate cohort analysis using the UK Biobank.
Urdiales T; Dernie F; Català M; Prats-Uribe A; Prats C; Prieto-Alhambra D
BMJ Open; 2023 Sep; 13(9):e074367. PubMed ID: 37734898
[TBL] [Abstract][Full Text] [Related]
23. Association between gout and cardiovascular outcomes in adults with no history of cardiovascular disease: large data linkage study in New Zealand.
Cai K; Wu B; Mehta S; Harwood M; Grey C; Dalbeth N; Wells SM; Jackson R; Poppe K
BMJ Med; 2022; 1(1):e000081. PubMed ID: 36936597
[TBL] [Abstract][Full Text] [Related]
24. Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study.
Roughley M; Sultan AA; Clarson L; Muller S; Whittle R; Belcher J; Mallen CD; Roddy E
Arthritis Res Ther; 2018 Oct; 20(1):243. PubMed ID: 30376864
[TBL] [Abstract][Full Text] [Related]
25. Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy.
Drivelegka P; Sigurdardottir V; Svärd A; Jacobsson LTH; Dehlin M
Arthritis Res Ther; 2018 Jun; 20(1):108. PubMed ID: 29855389
[TBL] [Abstract][Full Text] [Related]
26. Social deprivation as a risk factor for COVID-19 mortality among women and men in the UK Biobank: nature of risk and context suggests that social interventions are essential to mitigate the effects of future pandemics.
Woodward M; Peters SAE; Harris K
J Epidemiol Community Health; 2021 Nov; 75(11):1050-1055. PubMed ID: 33906905
[TBL] [Abstract][Full Text] [Related]
27. Disparities in COVID-19 infection, hospitalisation and death in people with schizophrenia, bipolar disorder, and major depressive disorder: a cohort study of the UK Biobank.
Hassan L; Peek N; Lovell K; Carvalho AF; Solmi M; Stubbs B; Firth J
Mol Psychiatry; 2022 Feb; 27(2):1248-1255. PubMed ID: 34873324
[TBL] [Abstract][Full Text] [Related]
28. Urate-lowering treatment and risk of total joint replacement in patients with gout.
Kuo CF; Chou IJ; See LC; Chen JS; Yu KH; Luo SF; Hsieh AH; Zhang W; Doherty M
Rheumatology (Oxford); 2018 Dec; 57(12):2129-2139. PubMed ID: 30060176
[TBL] [Abstract][Full Text] [Related]
29. Urate-lowering therapy adherence and the association with medication beliefs, self-efficacy, depression, anxiety, and COVID-19 pandemic-related concern in Chinese gout patients: a cross-sectional study.
Yin R; Lu J; Xu Z; Yan Q; Wang M; Xu R
Psychol Health Med; 2023; 28(7):1698-1708. PubMed ID: 37322811
[TBL] [Abstract][Full Text] [Related]
30. COVID-19 vaccination during pregnancy: coverage and safety.
Blakeway H; Prasad S; Kalafat E; Heath PT; Ladhani SN; Le Doare K; Magee LA; O'Brien P; Rezvani A; von Dadelszen P; Khalil A
Am J Obstet Gynecol; 2022 Feb; 226(2):236.e1-236.e14. PubMed ID: 34389291
[TBL] [Abstract][Full Text] [Related]
31. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
[TBL] [Abstract][Full Text] [Related]
32. Comparative efficacy of low-dose versus regular-dose colchicine to prevent flares in gout patients initiated on urate-lowering therapies.
Ahn SM; Oh JS; Hong S; Lee CK; Yoo B; Kim YG
Rheumatology (Oxford); 2021 Dec; 61(1):223-229. PubMed ID: 33764413
[TBL] [Abstract][Full Text] [Related]
33. Incident Gout: Risk of Death and Cause-Specific Mortality in Western Sweden: A Prospective, Controlled Inception Cohort Study.
Dehlin M; Sandström TZ; Jacobsson LT
Front Med (Lausanne); 2022; 9():802856. PubMed ID: 35280894
[TBL] [Abstract][Full Text] [Related]
34. Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England.
Russell MD; Roddy E; Rutherford AI; Ellis B; Norton S; Douiri A; Gulliford MC; Cope AP; Galloway JB
Rheumatology (Oxford); 2023 Jul; 62(7):2426-2434. PubMed ID: 36355461
[TBL] [Abstract][Full Text] [Related]
35. Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial.
Mackenzie IS; Ford I; Nuki G; Hallas J; Hawkey CJ; Webster J; Ralston SH; Walters M; Robertson M; De Caterina R; Findlay E; Perez-Ruiz F; McMurray JJV; MacDonald TM;
Lancet; 2020 Nov; 396(10264):1745-1757. PubMed ID: 33181081
[TBL] [Abstract][Full Text] [Related]
36. The influence of personality on the risk of myocardial infarction in UK Biobank cohort.
Dahlén AD; Miguet M; Schiöth HB; Rukh G
Sci Rep; 2022 Apr; 12(1):6706. PubMed ID: 35468914
[TBL] [Abstract][Full Text] [Related]
37. COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors.
Elliott J; Bodinier B; Whitaker M; Delpierre C; Vermeulen R; Tzoulaki I; Elliott P; Chadeau-Hyam M
Eur J Epidemiol; 2021 Mar; 36(3):299-309. PubMed ID: 33587202
[TBL] [Abstract][Full Text] [Related]
38. Variants in urate transporters, ADH1B, GCKR and MEPE genes associate with transition from asymptomatic hyperuricaemia to gout: results of the first gout versus asymptomatic hyperuricaemia GWAS in Caucasians using data from the UK Biobank.
Sandoval-Plata G; Morgan K; Abhishek A
Ann Rheum Dis; 2021 Sep; 80(9):1220-1226. PubMed ID: 33832965
[TBL] [Abstract][Full Text] [Related]
39. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study.
Gao M; Piernas C; Astbury NM; Hippisley-Cox J; O'Rahilly S; Aveyard P; Jebb SA
Lancet Diabetes Endocrinol; 2021 Jun; 9(6):350-359. PubMed ID: 33932335
[TBL] [Abstract][Full Text] [Related]
40. Association between adiposity outcomes and residential density: a full-data, cross-sectional analysis of 419 562 UK Biobank adult participants.
Sarkar C; Webster C; Gallacher J
Lancet Planet Health; 2017 Oct; 1(7):e277-e288. PubMed ID: 29851626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
